INmune Bio, Inc. - INMB Market Value
INmune Bio, Inc. (INMB) focuses on neuroinflammation therapies, where the primary catalysts are the XPro1595 trials against Alzheimer's disease and its oncology portfolio. The team brings together leading immunologists, fostering an environment for independent scientific research through option programs. The market capitalization stands at 0.03. The company's price chart is available below; meanwhile, the business's environmental impact remains minimal due to outsourced manufacturing.
Comprehensive metric breakdowns and analytics for INmune Bio Corporation (INMB)
- market price and analyst price targets:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
Total Debt to Capital INmune Bio, Inc.|INMB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital INmune Bio, Inc.|INMB - Company Aggregate Debts|Debt to Book Capitalization Ratio INmune Bio Corporation|INMB - Company Long-Term Loans and Borrowings|Company Short-Term Debt INmune Bio|Quick Ratio inmunebio.com
- financial results and valuation multiples details:
INMB - Net Profit|Future Profit INmune Bio, Inc.|INMB - Company Value to Net Income|Forward P/E Multiple INmune Bio Corp|INMB - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio Corporation|INMB - Operating profit before deduction of amortization|Earnings per share for the last twelve months INmune Bio|INMB - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months inmunebio.com|INMB - Earnings growth in current year|Net earnings per share growth forecast for next year INmune Bio, Inc.
Fundamental company analysis:INMB (INmune Bio)
Market capitalization represents the aggregate value of all outstanding shares, reflecting the current market valuation of the business. This metric is calculated as the product of the price per share and the total number of shares outstanding. By analyzing the history of a company's market capitalization, an investor can see the immediate market reaction to fundamental news. For INmune Bio, Inc. (INMB), the trend of this value depends directly on the prospects of the XPro molecule. The innovative approach to treating Alzheimer's creates a strategic asset that the market assesses through the prism of future revenues.
Key competitors
Market Value argenx ARGX|BNTX: Market Capitalization|ABVX - Market Value|ADMA Corp (ADMA) - Market Valuation|PTGX: Market Capitalization|IMVT (immunovant.com) - Market Value|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|Market Capitalization Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics (ACRS) - Market Value|Market Capitalization KYTX|Market Value Tiziana Life Sciences Ltd|Market Valuation Cabaletta Bio Inc. (CABA)|Market Valuation VTYX (Ventyx Bio)|Market Capitalization Theratechnologies, Inc (THTX)|Market Value Avalo Therapeutics, Inc AVTX|ELDN: Market Capitalization|Agenus Inc. - Market Capitalization|Market Value Climb Bio Inc.|ZURA (Zura Bio) - Market Valuation|aTyr Pharmaceuticals - Market Value|ADAG (Adagene Inc) - Market Capitalization|Market Value IMA|Market Capitalization STTK|Market Capitalization equilliumbio.com|Market Value Connect Biopharma Holdings Limited CNTB|Immunic Therapeutics (IMUX) - Market Value|ATRA: Market Valuation|Market Value IFRX (InflaRx N.V.)|XFOR: Market Capitalization|ACET - Market Capitalization|Market Value Celularity Inc|Market Capitalization BRNS (Barinthus Biotherapeutics Corp)|Market Capitalization KZR|Market Valuation sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Market Valuation|Market Capitalization Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp - Market Capitalization|Market Capitalization GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Market Value|Market Capitalization IBIO|Market Value Carisma Therapeutics Inc|Market Valuation XTL Biopharmaceuticals Ltd (XTLB)|Market Capitalization BOLT|Market Value HCWB (hcwbiologics.com)|Market Value Aptevo Therapeutics Inc. APVO|AIM (aimimmuno.com) - Market Valuation|Aditxt Corp - Market Capitalization|Market Value GRI (GRI Bio Inc)|XRTX: Market Capitalization|Vyome Therapeutics (HIND) - Market Capitalization|Market Value Revelation Biosciences|INDP: Market Value|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|Market Valuation calcimedica.com CALI|Market Capitalization AFMD (Affimed N.V.)|Market Capitalization Allakos Inc ALLK|HOOK: Market Valuation|Market Value IGMS (IGM Biosciences, Inc.)|ITOS: Market Capitalization|OCEA - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
